Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07215611) titled 'Financial Toxicity in Patients With Resected Soft Tissue and Bone Sarcomas' on Oct. 9.
Study Type: Observational
Primary Sponsor: M.D. Anderson Cancer Center
Condition:
Bone Sarcomas
Financial Toxicity
Intervention:
Other: data collection
Recruitment Status: Recruiting
Date of First Enrollment: September 2, 2025
Target Sample Size: 100
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07215611
Published by HT Digital Content Services with permission from Health Daily Digest....